Get startedLog in
    Picture of Cizzle Biotechnology Holdings logo

    CIZ — Cizzle Biotechnology Holdings News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Cizzle Biotechnology Signs MoU For Clinical Study For Lung Cancer Detection In China

    Picture of Cizzle Biotechnology Holdings logoCizzle Biotechnology Holdings
    23/11/2022 08:19
    Nov 23 (Reuters) - Cizzle Biotechnology Holdings PLC
 CIZ.L :
    * CIZZLE BIOTECHNOLOGY  - CLINICAL STUDY FOR LUNG CANCER
DETECTION
IN CHINA
    * CIZZLE BIOTECHNOLOGY -  SIGNED MOU FOR CLINICAL PILOT
STUDY WITH
CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES, NATIONAL
CANCER CENTER OF CHINA

Source text for Eikon:  ID:nRSW3340Ha 
Further company coverage:  CIZ.L 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cizzle Biotechnology Holdings

    See all news